Tag: Generic drugs ⋅ Page 1

Professor Lietzan Lectures on the Hatch-Waxman Amendments

Professor Erika Lietzan recently gave a lecture on the Hatch-Waxman Amendments as part of the Mason Judicial Education Program, a division of George Mason University’s Law & Economics Center (LEC). Professor Lietzan lectured for an hour on the Hatch-Waxman Amendments, which created a statutory pathway for approval of generic drugs as well as provisions governing the timing of that approval…

Professor Lietzan Featured on Webcast about New Uses for Established Drugs

On March 29, Professor Erika Lietzan was the featured speaker in a webcast from the Syracuse College of Law’s IP Tech Law Center.  She spoke with Shubha Ghosh about ensuring effective patent and regulatory exclusivity incentives for the development of new uses for already established drugs.  Her recent article on this topic, “Paper Promises for Drug Innovation” will be published…

Professor Lietzan Speaks at Conference about New Uses of Established Drugs

On February 8, Professor Erika Lietzan spoke at the conference, “Clinical Innovation: Fair and Effective Incentives for New Uses of Established Drugs,” convened in Washington, DC, by University College London (UCL) and the Georgetown University Law Center (GULC). This invitation-only conference gathered more than 40 experienced thought leaders — including scientists, industry executives, lawyers, law professors, business professors, judges, retired judges, and regulators, most with several decades of…